Notice of Pre-Application Webinar for Cellular Senescence Network (SenNet) RFAs: RFA-RM-21-008, RFA-RM-21-009, RFA-RM-21-010
Notice Number:

Key Dates

Release Date:

January 12, 2021

Related Announcements

RFA-RM-21-008 - Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed)
RFA-RM-21-009 - Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed)
RFA-RM-21-010 - Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed)

Issued by

Office of Strategic Coordination (Common Fund)


The NIH Common Fund will hold a pre-application interactive Q&A webinar on January 22, 2021 from 12:00-1:30PM (EDT) for Cellular Senescence Network (SenNet) RFA funding opportunities: RFA-RM-21-008, RFA-RM-21-009, and RFA-RM-21-010. NIH program and review staff will discuss the funding opportunities and answer questions from the applicants. All prospective applicants are invited to participate. Participation in the webinar is optional. A recording of the webinar will not be posted online, but the slides and resultant Frequently Asked Questions (FAQs) and their answers will be posted on If you plan to attend the webinar and require reasonable accommodation such as a sign language interpreter, please contact

Webinar Information

The Webinar will be hosted through Webex.Questions may be submitted to prior to the webinar or may be submitted during the webinar. Submitted questions will be answered as time permits.

Date: Friday, Jan 22, 2021 12:00 pm | 1 hour 30 minutes | (UTC-05:00) Eastern Time (US & Canada)

Meeting number: 126 463 3177

Password: Senescence

Join by video system


You can also dial and enter your meeting number

Access code: 126 463 3177

Join by phone

1-650-479-3208 Call-in toll number (US/Canada)

Access code: 126 463 3177


Please direct all inquiries to:

Felipe Sierra, Ph.D.
National Institute on Aging (NIA)
Telephone: 240.338.9544

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices